Targeting Angiogenesis with Multitargeted Tyrosine Kinase Inhibitors in the Treatment of Non-Small Cell Lung Cancer
Abstract It has been >35 years since the link between angiogenesis and the growth of tumors was first reported. Targeting angiogenesis became feasible with the availability of bevacizumab, an anti–vascular endothelial growth factor monoclonal antibody. Initial studies revealed that the co...
Saved in:
| Main Authors: | , |
|---|---|
| 格式: | Revisão |
| 语言: | 英语 |
| 出版: |
2010
|
| 在线阅读: | https://doi.org/10.1634/theoncologist.2009-0225 https://academic.oup.com/oncolo/article-pdf/15/5/436/41843324/oncolo_15_5_436.pdf |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|